Ph.D. Candidate
Taipei Medical University
Taipei, Taipei, Taiwan (Republic of China)
Ho Thi Luu is a Ph.D. candidate in the International Ph.D. Program in Cell Therapy and Regenerative Medicine at Taipei Medical University, Taiwan. Her research focuses on engineering cell membrane-derived nanovesicles for therapeutic applications, including drug delivery and cancer treatment. She is particularly interested in investigating immune system responses to drug delivery systems, aiming to optimize biocompatibility and develop targeted therapeutic strategies.
Disclosure information not submitted.
Development of Hybrid Cell Membrane Nanovesicles for Enhanced Pancreatic Cancer Treatment
Wednesday, July 16, 2025
3:49 PM – 4:00 PM EDT